Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Janux Therapeutics (JANX) Non Operating Income: 2020-2024

Historic Non Operating Income for Janux Therapeutics (JANX) over the last 5 years, with Dec 2024 value amounting to $29.9 million.

  • Janux Therapeutics' Non Operating Income rose 40.54% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.4 million, marking a year-over-year increase of 66.73%. This contributed to the annual value of $29.9 million for FY2024, which is 103.28% up from last year.
  • Latest data reveals that Janux Therapeutics reported Non Operating Income of $29.9 million as of FY2024, which was up 103.28% from $14.7 million recorded in FY2023.
  • Janux Therapeutics' 5-year Non Operating Income high stood at $29.9 million for FY2024, and its period low was -$1.9 million during FY2020.
  • In the last 3 years, Janux Therapeutics' Non Operating Income had a median value of $14.7 million in 2023 and averaged $16.2 million.
  • Data for Janux Therapeutics' Non Operating Income shows a peak YoY skyrocketed of 1,468.87% (in 2022) over the last 5 years.
  • Janux Therapeutics' Non Operating Income (Yearly) stood at -$1.9 million in 2020, then surged by 113.24% to $257,000 in 2021, then soared by 1,468.87% to $4.0 million in 2022, then soared by 264.24% to $14.7 million in 2023, then soared by 103.28% to $29.9 million in 2024.